SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引：5

作者：

Cui, J. Y. ^{[1
]}

Philo, L. ^{[2
]}

Nguyen, P. ^{[1
]}

Hofflich, H. ^{[3
]}

Hernandez, C. ^{[1
]}

Bettencourt, R. ^{[4
]}

Richards, L. ^{[1
]}

Salotti, J. ^{[1
]}

Bhatt, A. ^{[1
]}

Hooker, J. ^{[5
]}

Haufe, W. ^{[5
]}

Hooker, C. ^{[1
]}

Brenner, D. A. ^{[6
]}

Sirlin, C. B. ^{[5
]}

Loomba, R. ^{[1
,4
,6
,7
]}

机构：

[1] UC San Diego Sch Med, Dept Med, NAFLD Res Ctr, La Jolla, CA USA

[2] Naval Med Ctr, San Diego, CA USA

[3] UC San Diego Sch Med, Div Gen Internal Med, La Jolla, CA USA

[4] UC San Diego Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA USA

[5] UC San Diego Sch Med, Dept Radiol, Liver Imaging Grp, La Jolla, CA USA

[6] UC San Diego Sch Med, Dept Med, Div Gastroenterol, La Jolla, CA USA

[7] San Diego Integrated NAFLD Consortium, San Diego, CA USA

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)00137-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS112

引用

页码：S192 / S193

页数：2

共 50 条

[41] Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial [J].

Varkaneh, Hamed Kord ;

Sahlabadi, Ammar Salehi ;

Gaman, Mihnea-Alexandru ;

Rajabnia, Mohsen ;

Macit-Celebi, Melahat Sedanur ;

Santos, Heitor O. ;

Hekmatdoost, Azita .

FRONTIERS IN NUTRITION, 2022, 9

[42] The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial [J].

Zahra Yari ;

Makan Cheraghpour ;

Seyed Moayed Alavian ;

Mehdi Hedayati ;

Hassan Eini-Zinab ;

Azita Hekmatdoost .

European Journal of Clinical Nutrition, 2021, 75 :99-111

[43] The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial [J].

Yari, Zahra ;

Cheraghpour, Makan ;

Alavian, Seyed Moayed ;

Hedayati, Mehdi ;

Eini-Zinab, Hassan ;

Hekmatdoost, Azita .

EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2021, 75 (01) :99-111

[44] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol [J].

Lambert, Jennifer E. ;

Parnell, Jill A. ;

Eksteen, Bertus ;

Raman, Maitreyi ;

Bomhof, Marc R. ;

Rioux, Kevin P. ;

Madsen, Karen L. ;

Reimer, Raylene A. .

BMC GASTROENTEROLOGY, 2015, 15

[45] The efficacy of silymarin in decreasing transaminase activities in non-alcoholic fatty liver disease: A randomized controlled clinical trial [J].

Hajaghamohammadi, Ali-Akbar ;

Ziaee, Amir ;

Rafiei, Ramin .

HEPATITIS MONTHLY, 2008, 8 (03) :191-195

[46] Current treatment of non-alcoholic fatty liver disease [J].

Ahmed, Mohamed H. ;

Byrne, Christopher D. .

DIABETES OBESITY & METABOLISM, 2009, 11 (03) :188-195

[47] Pharmacological Treatment for Non-alcoholic Fatty Liver Disease [J].

Francque, Sven ;

Vonghia, Luisa .

ADVANCES IN THERAPY, 2019, 36 (05) :1052-1074

[48] Metformin in the treatment of non-alcoholic fatty liver disease [J].

De Lusong, M. A. .

JOURNAL OF CLINICAL VIROLOGY, 2006, 36 :S192-S192

[49] Pharmacological Treatment for Non-alcoholic Fatty Liver Disease [J].

Sven Francque ;

Luisa Vonghia .

Advances in Therapy, 2019, 36 :1052-1074

[50] Rosiglitazone treatment in non-alcoholic fatty liver disease [J].

Szymanska-Garbacz, E. ;

Saryusz-Wolska, M. ;

Jablkowski, M. ;

Bialkowska, J. ;

Borkowska, A. ;

Omulecka, A. ;

Loba, J. ;

Czupryniak, L. .

DIABETOLOGIA, 2008, 51 :S368-S368

← 1 2 3 4 5 →